Report Detail
Global Remicade Biosimilar Market Research Report 2019
- RnM3144009 |
- 04 August, 2020 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Remicade Biosimilar market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Remicade Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Remicade Biosimilar market is segmented into
100mg/10ml
500mg/50ml
Segment by Application, the Remicade Biosimilar market is segmented into
Blood Disorders
Oncology Diseases
Regional and Country-level Analysis
The Remicade Biosimilar market is analysed and market size information is provided by regions (countries).
The key regions covered in the Remicade Biosimilar market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Remicade Biosimilar Market Share Analysis
Remicade Biosimilar market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Remicade Biosimilar business, the date to enter into the Remicade Biosimilar market, Remicade Biosimilar product introduction, recent developments, etc.
The major vendors covered:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
1 Study Coverage
- 1.1 Remicade Biosimilar Product Introduction
- 1.2 Market Segments
- 1.3 Key Remicade Biosimilar Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Remicade Biosimilar Market Size Growth Rate by Type
- 1.4.2 100mg/10ml
- 1.4.3 500mg/50ml
- 1.5 Market by Application
- 1.5.1 Global Remicade Biosimilar Market Size Growth Rate by Application
- 1.5.2 Blood Disorders
- 1.5.3 Oncology Diseases
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Remicade Biosimilar Market Size, Estimates and Forecasts
- 2.1.1 Global Remicade Biosimilar Revenue 2015-2026
- 2.1.2 Global Remicade Biosimilar Sales 2015-2026
- 2.2 Global Remicade Biosimilar, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Remicade Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Remicade Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Remicade Biosimilar Competitor Landscape by Players
- 3.1 Remicade Biosimilar Sales by Manufacturers
- 3.1.1 Remicade Biosimilar Sales by Manufacturers (2015-2020)
- 3.1.2 Remicade Biosimilar Sales Market Share by Manufacturers (2015-2020)
- 3.2 Remicade Biosimilar Revenue by Manufacturers
- 3.2.1 Remicade Biosimilar Revenue by Manufacturers (2015-2020)
- 3.2.2 Remicade Biosimilar Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Remicade Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Remicade Biosimilar Revenue in 2019
- 3.2.5 Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Remicade Biosimilar Price by Manufacturers
- 3.4 Remicade Biosimilar Manufacturing Base Distribution, Product Types
- 3.4.1 Remicade Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Remicade Biosimilar Product Type
- 3.4.3 Date of International Manufacturers Enter into Remicade Biosimilar Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Remicade Biosimilar Market Size by Type (2015-2020)
- 4.1.1 Global Remicade Biosimilar Sales by Type (2015-2020)
- 4.1.2 Global Remicade Biosimilar Revenue by Type (2015-2020)
- 4.1.3 Remicade Biosimilar Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Remicade Biosimilar Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Remicade Biosimilar Sales Forecast by Type (2021-2026)
- 4.2.2 Global Remicade Biosimilar Revenue Forecast by Type (2021-2026)
- 4.2.3 Remicade Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Remicade Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Remicade Biosimilar Market Size by Application (2015-2020)
- 5.1.1 Global Remicade Biosimilar Sales by Application (2015-2020)
- 5.1.2 Global Remicade Biosimilar Revenue by Application (2015-2020)
- 5.1.3 Remicade Biosimilar Price by Application (2015-2020)
- 5.2 Remicade Biosimilar Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Remicade Biosimilar Sales Forecast by Application (2021-2026)
- 5.2.2 Global Remicade Biosimilar Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Remicade Biosimilar Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Remicade Biosimilar by Country
- 6.1.1 North America Remicade Biosimilar Sales by Country
- 6.1.2 North America Remicade Biosimilar Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Remicade Biosimilar Market Facts & Figures by Type
- 6.3 North America Remicade Biosimilar Market Facts & Figures by Application
7 Europe
- 7.1 Europe Remicade Biosimilar by Country
- 7.1.1 Europe Remicade Biosimilar Sales by Country
- 7.1.2 Europe Remicade Biosimilar Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Remicade Biosimilar Market Facts & Figures by Type
- 7.3 Europe Remicade Biosimilar Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Remicade Biosimilar by Region
- 8.1.1 Asia Pacific Remicade Biosimilar Sales by Region
- 8.1.2 Asia Pacific Remicade Biosimilar Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Remicade Biosimilar Market Facts & Figures by Type
- 8.3 Asia Pacific Remicade Biosimilar Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Remicade Biosimilar by Country
- 9.1.1 Latin America Remicade Biosimilar Sales by Country
- 9.1.2 Latin America Remicade Biosimilar Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Remicade Biosimilar Market Facts & Figures by Type
- 9.3 Central & South America Remicade Biosimilar Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Remicade Biosimilar by Country
- 10.1.1 Middle East and Africa Remicade Biosimilar Sales by Country
- 10.1.2 Middle East and Africa Remicade Biosimilar Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Type
- 10.3 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Application
11 Company Profiles
- 11.1 Synthon Pharmaceuticals
- 11.1.1 Synthon Pharmaceuticals Corporation Information
- 11.1.2 Synthon Pharmaceuticals Description and Business Overview
- 11.1.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
- 11.1.5 Synthon Pharmaceuticals Related Developments
- 11.2 LG Life Sciences
- 11.2.1 LG Life Sciences Corporation Information
- 11.2.2 LG Life Sciences Description and Business Overview
- 11.2.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 LG Life Sciences Remicade Biosimilar Products Offered
- 11.2.5 LG Life Sciences Related Developments
- 11.3 Novartis (Sandoz)
- 11.3.1 Novartis (Sandoz) Corporation Information
- 11.3.2 Novartis (Sandoz) Description and Business Overview
- 11.3.3 Novartis (Sandoz) Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Novartis (Sandoz) Remicade Biosimilar Products Offered
- 11.3.5 Novartis (Sandoz) Related Developments
- 11.4 Celltrion
- 11.4.1 Celltrion Corporation Information
- 11.4.2 Celltrion Description and Business Overview
- 11.4.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Celltrion Remicade Biosimilar Products Offered
- 11.4.5 Celltrion Related Developments
- 11.5 Biocon
- 11.5.1 Biocon Corporation Information
- 11.5.2 Biocon Description and Business Overview
- 11.5.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Biocon Remicade Biosimilar Products Offered
- 11.5.5 Biocon Related Developments
- 11.6 Hospira
- 11.6.1 Hospira Corporation Information
- 11.6.2 Hospira Description and Business Overview
- 11.6.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Hospira Remicade Biosimilar Products Offered
- 11.6.5 Hospira Related Developments
- 11.7 Merck Serono (Merck Group)
- 11.7.1 Merck Serono (Merck Group) Corporation Information
- 11.7.2 Merck Serono (Merck Group) Description and Business Overview
- 11.7.3 Merck Serono (Merck Group) Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Merck Serono (Merck Group) Remicade Biosimilar Products Offered
- 11.7.5 Merck Serono (Merck Group) Related Developments
- 11.8 Biogen idec Inc.
- 11.8.1 Biogen idec Inc. Corporation Information
- 11.8.2 Biogen idec Inc. Description and Business Overview
- 11.8.3 Biogen idec Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Biogen idec Inc. Remicade Biosimilar Products Offered
- 11.8.5 Biogen idec Inc. Related Developments
- 11.9 Genentech (Roche Group)
- 11.9.1 Genentech (Roche Group) Corporation Information
- 11.9.2 Genentech (Roche Group) Description and Business Overview
- 11.9.3 Genentech (Roche Group) Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Genentech (Roche Group) Remicade Biosimilar Products Offered
- 11.9.5 Genentech (Roche Group) Related Developments
- 11.1 Synthon Pharmaceuticals
- 11.1.1 Synthon Pharmaceuticals Corporation Information
- 11.1.2 Synthon Pharmaceuticals Description and Business Overview
- 11.1.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
- 11.1.5 Synthon Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Remicade Biosimilar Market Estimates and Projections by Region
- 12.1.1 Global Remicade Biosimilar Sales Forecast by Regions 2021-2026
- 12.1.2 Global Remicade Biosimilar Revenue Forecast by Regions 2021-2026
- 12.2 North America Remicade Biosimilar Market Size Forecast (2021-2026)
- 12.2.1 North America: Remicade Biosimilar Sales Forecast (2021-2026)
- 12.2.2 North America: Remicade Biosimilar Revenue Forecast (2021-2026)
- 12.2.3 North America: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
- 12.3 Europe Remicade Biosimilar Market Size Forecast (2021-2026)
- 12.3.1 Europe: Remicade Biosimilar Sales Forecast (2021-2026)
- 12.3.2 Europe: Remicade Biosimilar Revenue Forecast (2021-2026)
- 12.3.3 Europe: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Remicade Biosimilar Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Remicade Biosimilar Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Remicade Biosimilar Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Remicade Biosimilar Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Remicade Biosimilar Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Remicade Biosimilar Sales Forecast (2021-2026)
- 12.5.2 Latin America: Remicade Biosimilar Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Remicade Biosimilar Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Remicade Biosimilar Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Remicade Biosimilar Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Remicade Biosimilar Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Remicade Biosimilar Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Remicade Biosimilar. Industry analysis & Market Report on Remicade Biosimilar is a syndicated market report, published as Global Remicade Biosimilar Market Research Report 2019. It is complete Research Study and Industry Analysis of Remicade Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
